Magnetic Resonance–Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: OHTAC Recommendation
Ontario Health Technology Advisory Committee (OHTAC)
Record ID 32015000482
English
Authors' recommendations:
Based on the current available evidence, OHTAC recommends that magnetic resonance–guided high-intensity focused ultrasound (MRgHIFU) be considered as one option in the treatment of symptomatic uterine fibroids in women who are unresponsive to medical therapy.
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
http://www.hqontario.ca/Portals/0/Documents/eds/ohtas/recommendation-mrghifu-1503-en.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Magnetic Resonance Spectroscopy
- Uterine Neoplasms
- Magnetic Resonance Imaging
Contact
Organisation Name:
Health Quality Ontario
Contact Address:
Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5
Contact Name:
EDSinfo@hqontario.ca
Contact Email:
OH-HQO_hta-reg@ontariohealth.ca
Copyright:
Health Quality Ontario
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.